Abeta Targets of the Biosimilar Antibodies of Bapineuzumab, Crenezumab, Solanezumab in Comparison to an Antibody Against N-Truncated Abeta in Sporadic Alzheimer Disease Cases and Mouse Models
AuthID
P-015-PAS
P-015-PAS